Dacomitinib Hydrate
Dacomitinib Hydrate, sold under the brand name Vizimpro, is a medication for the treatment of non-small-cell lung carcinoma. Reference standards of Dacomitinib Hydrate API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
stdClass Object
(
[pname] => Dacomitinib Hydrate
[catalogue_number] => PA 04 2980000
[category_ids] => ,75,78,79,82,
[chemical_name] =>
[weight] => 487.96
[form] => C24H27ClFN5O3
[cas] => 1042385-75-0
[pslug] => 1042385-75-0-dacomitinib-hydrate-api-standards-pa042980000
[latest_product] => 0
[linkproducts] => 1
[offers_id] =>
[offers_name] =>
[offers_status] =>
[offers_start_date] =>
[offers_end_date] =>
[pageview] =>
[offers_slug] =>
[offers_product_id] =>
[offers_product_code] =>
[offers_master_id] =>
[offer_percentage] =>
[offers_product_main_cat] =>
)
Catalogue No.:PA 04 2980000
Molecular Formula : C24H27ClFN5O3
Molecular Weight : 487.96